Original Research
Accepted on 26 Jul 2024
Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409271
Type at least 3 characters
529 articles
Articles
Original Research
Published on 26 Jul 2024
Colquhounia root tablet improves diabetic kidney disease by regulating epithelial-mesenchymal transition via the PTEN/PI3K/AKT pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418588
Review
Published on 25 Jul 2024
Opioids and the kidney: two sides of the same coin
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421248
Correction
Published on 23 Jul 2024
Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD–MBD model rats by targeting FGF23-Klotho signaling axis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446609
- 119 views
Review
Published on 22 Jul 2024
Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421657
- 140 views
Systematic Review
Published on 19 Jul 2024
Effects and safety of Ophiocordyceps sinensis preparation in the adjuvant treatment for dialysis patients: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1360997
- 189 views
Review
Accepted on 17 Jul 2024
A New Perspective on Proteinuria and Drug Therapy for Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1349022
Original Research
Published on 17 Jul 2024
THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430451
- 306 views
Original Research
Published on 17 Jul 2024
The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1379821
- 232 views
Original Research
Published on 17 Jul 2024
Acrylamide-targeting renal miR−21a−5p/Fibrotic and miR122-5p/ inflammatory signaling pathways and the role of a green approach for nano-zinc detected via in silico and in vivo approaches
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413844
- 230 views
Review
Published on 17 Jul 2024
Mapping the global research landscape on depression for patients with chronic kidney disease: a bibliometric and visualized analysis from 2006 to 2022
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388641
- 130 views
Original Research
Accepted on 16 Jul 2024
Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418485
Original Research
Published on 15 Jul 2024
Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409654
- 223 views
Review
Published on 10 Jul 2024
Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406588
- 251 views
Original Research
Published on 09 Jul 2024
Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414918
- 329 views
Original Research
Accepted on 05 Jul 2024
Piperazine ferulate inhibits diabetic nephropathy by suppressing AGE/RAGE-mediated inflammatory signaling in rats and podocytes
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394369